ID

16958

Description

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries; ODM derived from: https://clinicaltrials.gov/show/NCT00148356

Link

https://clinicaltrials.gov/show/NCT00148356

Keywords

Versions (1)
  1. 8/16/16 8/16/16 -
Uploaded on

August 16, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Coronary Disease NCT00148356

English

Eligibility Coronary Disease NCT00148356

1 forms  
Criteria
Description

Criteria

subject is ≥ 18 years old.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
female of childbearing potential must have a negative pregnancy test within 7 days prior to enrollment and utilize reliable birth control for nine (9) months after enrollment.
Description

Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0427780
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
subject is eligible for percutaneous coronary intervention (pci) and has a single lesion requiring treatment.
Description

Indication Percutaneous Coronary Intervention | Single lesion Requirement Therapeutic procedure

Data type

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C1532338
UMLS CUI [2,1]
C0577304
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0087111
subject is an acceptable candidate for cabg.
Description

Indication Coronary Artery Bypass Surgery

Data type

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0010055
subject has clinical evidence of ischemic heart disease or a positive functional study.
Description

Myocardial Ischemia Evidence Clinical | Cardiac Function Study Positive

Data type

boolean

Alias
UMLS CUI [1,1]
C0151744
UMLS CUI [1,2]
C0332120
UMLS CUI [1,3]
C0205210
UMLS CUI [2,1]
C1516291
UMLS CUI [2,2]
C1446409
subject has documented stable angina pectoris
Description

Stable angina

Data type

boolean

Alias
UMLS CUI [1]
C0340288
exclusion criteria include all of the following:
Description

Exclusion Criteria

Data type

boolean

Alias
UMLS CUI [1]
C0680251
evidence of an acute myocardial infarction (ami) or ck-mb > 2x upper limit of normal within 72 hours of the intended treatment (refer to who definition).
Description

Acute myocardial infarction Evidence of | Creatine kinase MB measurement

Data type

boolean

Alias
UMLS CUI [1,1]
C0155626
UMLS CUI [1,2]
C0332120
UMLS CUI [2]
C0523584
known allergies to the following: aspirin, clopidogrel bisulfate (plavix®) or ticlopidine (ticlid®), heparin, stainless steel, tantalum, contrast agent (that cannot be adequately premedicated), paclitaxel, or drugs similar to abt-578 (i.e. tacrolimus, sirolimus, everolimus).
Description

Hypersensitivity Aspirin | Hypersensitivity Clopidogrel bisulfate | Hypersensitivity Plavix | Hypersensitivity Ticlopidine | Hypersensitivity Ticlid | Hypersensitivity Heparin | Hypersensitivity Stainless Steel | Hypersensitivity Tantalum | Hypersensitivity Contrast Media | Hypersensitivity Paclitaxel | Hypersensitivity ABT-578 | Hypersensitivity Tacrolimus | Hypersensitivity Sirolimus | Hypersensitivity everolimus

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0004057
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0772326
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0633084
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0040207
UMLS CUI [5,1]
C0020517
UMLS CUI [5,2]
C0733418
UMLS CUI [6,1]
C0020517
UMLS CUI [6,2]
C0019134
UMLS CUI [7,1]
C0020517
UMLS CUI [7,2]
C0038126
UMLS CUI [8,1]
C0020517
UMLS CUI [8,2]
C0039297
UMLS CUI [9,1]
C0020517
UMLS CUI [9,2]
C0009924
UMLS CUI [10,1]
C0020517
UMLS CUI [10,2]
C0144576
UMLS CUI [11,1]
C0020517
UMLS CUI [11,2]
C2350862
UMLS CUI [12,1]
C0020517
UMLS CUI [12,2]
C0085149
UMLS CUI [13,1]
C0020517
UMLS CUI [13,2]
C0072980
UMLS CUI [14,1]
C0020517
UMLS CUI [14,2]
C0541315
a platelet count < 100 x 109/l or > 700 x 109/l (< 100,000 cells/mm3 or > 700,000 cells/mm3); a wbc < 3,000 cells/mm3; or a hemoglobin < 10.0 g/dl.
Description

Platelet Count measurement | White Blood Cell Count procedure | Hemoglobin

Data type

boolean

Alias
UMLS CUI [1]
C0032181
UMLS CUI [2]
C0023508
UMLS CUI [3]
C0019046
acute or chronic renal dysfunction (creatinine > 2.0 mg/dl or > 150 µmol/l).
Description

Renal dysfunction | Renal dysfunction chronic | Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C3279454
UMLS CUI [2,1]
C3279454
UMLS CUI [2,2]
C0205191
UMLS CUI [3]
C0201976
subject has had any previous or planned brachytherapy in the target vessel.
Description

Brachytherapy Target vessel

Data type

boolean

Alias
UMLS CUI [1,1]
C0006098
UMLS CUI [1,2]
C0449618
target vessel has evidence of thrombus or is excessively tortuous (> 60 degree bend) that makes it unsuitable for proper stent delivery and deployment.
Description

Target vessel Thrombus Evidence of | Target vessel Tortuous Excessive | Target vessel Inappropriate Placement of stent

Data type

boolean

Alias
UMLS CUI [1,1]
C0449618
UMLS CUI [1,2]
C0087086
UMLS CUI [1,3]
C0332120
UMLS CUI [2,1]
C0449618
UMLS CUI [2,2]
C4068863
UMLS CUI [2,3]
C0442802
UMLS CUI [3,1]
C0449618
UMLS CUI [3,2]
C1548788
UMLS CUI [3,3]
C0522776
Back to the top of the page

Similar models

Eligibility Coronary Disease NCT00148356

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Age
Item
subject is ≥ 18 years old.
boolean
C0001779 (UMLS CUI [1])
Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods
Item
female of childbearing potential must have a negative pregnancy test within 7 days prior to enrollment and utilize reliable birth control for nine (9) months after enrollment.
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Indication Percutaneous Coronary Intervention | Single lesion Requirement Therapeutic procedure
Item
subject is eligible for percutaneous coronary intervention (pci) and has a single lesion requiring treatment.
boolean
C3146298 (UMLS CUI [1,1])
C1532338 (UMLS CUI [1,2])
C0577304 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
Indication Coronary Artery Bypass Surgery
Item
subject is an acceptable candidate for cabg.
boolean
C3146298 (UMLS CUI [1,1])
C0010055 (UMLS CUI [1,2])
Myocardial Ischemia Evidence Clinical | Cardiac Function Study Positive
Item
subject has clinical evidence of ischemic heart disease or a positive functional study.
boolean
C0151744 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
C1516291 (UMLS CUI [2,1])
C1446409 (UMLS CUI [2,2])
Stable angina
Item
subject has documented stable angina pectoris
boolean
C0340288 (UMLS CUI [1])
Exclusion Criteria
Item
exclusion criteria include all of the following:
boolean
C0680251 (UMLS CUI [1])
Acute myocardial infarction Evidence of | Creatine kinase MB measurement
Item
evidence of an acute myocardial infarction (ami) or ck-mb > 2x upper limit of normal within 72 hours of the intended treatment (refer to who definition).
boolean
C0155626 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0523584 (UMLS CUI [2])
Hypersensitivity Aspirin | Hypersensitivity Clopidogrel bisulfate | Hypersensitivity Plavix | Hypersensitivity Ticlopidine | Hypersensitivity Ticlid | Hypersensitivity Heparin | Hypersensitivity Stainless Steel | Hypersensitivity Tantalum | Hypersensitivity Contrast Media | Hypersensitivity Paclitaxel | Hypersensitivity ABT-578 | Hypersensitivity Tacrolimus | Hypersensitivity Sirolimus | Hypersensitivity everolimus
Item
known allergies to the following: aspirin, clopidogrel bisulfate (plavix®) or ticlopidine (ticlid®), heparin, stainless steel, tantalum, contrast agent (that cannot be adequately premedicated), paclitaxel, or drugs similar to abt-578 (i.e. tacrolimus, sirolimus, everolimus).
boolean
C0020517 (UMLS CUI [1,1])
C0004057 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0772326 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0633084 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0040207 (UMLS CUI [4,2])
C0020517 (UMLS CUI [5,1])
C0733418 (UMLS CUI [5,2])
C0020517 (UMLS CUI [6,1])
C0019134 (UMLS CUI [6,2])
C0020517 (UMLS CUI [7,1])
C0038126 (UMLS CUI [7,2])
C0020517 (UMLS CUI [8,1])
C0039297 (UMLS CUI [8,2])
C0020517 (UMLS CUI [9,1])
C0009924 (UMLS CUI [9,2])
C0020517 (UMLS CUI [10,1])
C0144576 (UMLS CUI [10,2])
C0020517 (UMLS CUI [11,1])
C2350862 (UMLS CUI [11,2])
C0020517 (UMLS CUI [12,1])
C0085149 (UMLS CUI [12,2])
C0020517 (UMLS CUI [13,1])
C0072980 (UMLS CUI [13,2])
C0020517 (UMLS CUI [14,1])
C0541315 (UMLS CUI [14,2])
Platelet Count measurement | White Blood Cell Count procedure | Hemoglobin
Item
a platelet count < 100 x 109/l or > 700 x 109/l (< 100,000 cells/mm3 or > 700,000 cells/mm3); a wbc < 3,000 cells/mm3; or a hemoglobin < 10.0 g/dl.
boolean
C0032181 (UMLS CUI [1])
C0023508 (UMLS CUI [2])
C0019046 (UMLS CUI [3])
Renal dysfunction | Renal dysfunction chronic | Creatinine measurement, serum
Item
acute or chronic renal dysfunction (creatinine > 2.0 mg/dl or > 150 µmol/l).
boolean
C3279454 (UMLS CUI [1])
C3279454 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0201976 (UMLS CUI [3])
Brachytherapy Target vessel
Item
subject has had any previous or planned brachytherapy in the target vessel.
boolean
C0006098 (UMLS CUI [1,1])
C0449618 (UMLS CUI [1,2])
Target vessel Thrombus Evidence of | Target vessel Tortuous Excessive | Target vessel Inappropriate Placement of stent
Item
target vessel has evidence of thrombus or is excessively tortuous (> 60 degree bend) that makes it unsuitable for proper stent delivery and deployment.
boolean
C0449618 (UMLS CUI [1,1])
C0087086 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,3])
C0449618 (UMLS CUI [2,1])
C4068863 (UMLS CUI [2,2])
C0442802 (UMLS CUI [2,3])
C0449618 (UMLS CUI [3,1])
C1548788 (UMLS CUI [3,2])
C0522776 (UMLS CUI [3,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial